Outcomes of cingulate epilepsy surgery: insights from an institutional and patient-level systematic review and meta-analysis

被引:6
|
作者
Kerezoudis, Panagiotis [1 ]
Singh, Rohin [2 ]
Worrell, Gregory A. [3 ]
Van Gompel, Jamie J. [1 ]
机构
[1] Mayo Clin, Dept Neurol Surg, Rochester, MN USA
[2] Mayo Clin Alix Sch Med, Scottsdale, AZ USA
[3] Mayo Clin, Dept Neurol, Rochester, MN USA
关键词
KEYWORDS epilepsy surgery; seizure freedom; cingulate gyrus; systematic review; meta; -analysis; functional; neurosurgery; SUPPLEMENTARY MOTOR AREA; POSTERIOR CINGULATE; GYRUS EPILEPSY; SEIZURES; CHILD; CYTOLOGY; CORTEX;
D O I
10.3171/2021.8.JNS211558
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE Due to their deep and medial location, range of seizure semiologies, and poor localization on ictal electroencephalography (EEG), cingulate gyrus seizures can be difficult to diagnose and treat. The aim of this study was to review the available evidence on postoperative outcomes after cingulate epilepsy surgery. METHODS A comprehensive literature search of the PubMed/MEDLINE, Ovid Embase, Ovid Scopus, and Cochrane Library databases was conducted to identify studies that investigated postoperative outcomes of patients with cingulate epilepsy. Seizure freedom at the last follow-up (at least 12 months) was the primary endpoint. The literature search was supplemented by the authors' institutional series (4 patients). RESULTS Twenty-one studies were identified, yielding a total of 105 patients (68 with lesional epilepsy [65%]). Median age at surgery was 23 years, and 56% of patients were male. Median epilepsy duration was 7.5 years. Invasive EEG recording was performed on 69% of patients (53% of patients with lesional epilepsy and 97% of those with nonlesional epilepsy, p < 0.001). The most commonly resected region was the anterior cingulate (55%), followed by the posterior (17%) and middle (14%) cingulate. Lesionectomy alone was performed in 9% of patients. Additional extracingulate treatment was performed in 54% of patients (53% of patients with lesional epilepsy vs 57% of those with nonlesional epilepsy, p = 0.87). The most common pathology was cortical dysplasia (54%), followed by low-grade neoplasm (29%) and gliosis (8%). Seizure freedom was noted in 72% of patients (median follow-up 24 months). A neurological deficit was noted in 27% of patients (24% had temporary deficit), with the most common deficit being motor weakness (13%) followed by supplementary motor area syndrome (9.5%). Univariate survival analysis revealed significantly greater probability of seizure freedom in patients with lesional epilepsy (p = 0.015, log-rank test). CONCLUSIONS Surgical treatment of drug-resistant focal epilepsy originating from the cingulate gyrus is safe, leads to low rates of permanent adverse effects, and leads to high rates of long-term seizure freedom in carefully selected patients. These data may serve as a benchmark for surgical counseling of patients with cingulate epilepsy.
引用
收藏
页码:199 / 208
页数:10
相关论文
共 50 条
  • [31] Meta-analysis of patient-level clinical trials data
    Sutherland, LR
    Faris, PD
    Youssefi, M
    Hogerman, D
    Martin, CF
    LaFrance, N
    Alberta, C
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S249 - S249
  • [32] Effect of Resident Involvement in Ophthalmic Surgery on Patient Outcomes: A Systematic Review and Meta-analysis
    Cheng, John Yu
    Tsay, Katherine
    Sung, Jaemyoung
    Beigelman, Steven Isaac
    Coughlin, Emily
    Robinson, Avi S.
    Mhaskar, Rahul
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2023, 249 : 144 - 155
  • [33] A Patient-Level Data Meta-analysis of the Abscopal Effect
    Hatten, Steven J., Jr.
    Lehrer, Eric J.
    Liao, Jenn
    Sha, Congzhou M.
    Trifiletti, Daniel M.
    Siva, Shankar
    McBride, Sean M.
    Palma, David
    Holder, Sheldon L.
    Zaorsky, Nicholas G.
    ADVANCES IN RADIATION ONCOLOGY, 2022, 7 (03)
  • [34] A Patient-level Data Meta-analysis of the Abscopal Effect
    Hatten, Steven
    Lehrer, Eric
    Liao, Jenn
    Sha, Mike
    Trifiletti, Daniel
    Siva, Shankar
    McBride, Sean
    Palma, David
    Holder, Sheldon
    Zaorsky, Nicholas
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (10): : S113 - S113
  • [35] Surgical outcomes in adults with purpura fulminans: a systematic review and patient-level meta-synthesis
    Klifto, Kevin M.
    Gurno, Caresse F.
    Grzelak, Michael J.
    Seal, Stella M.
    Asif, Mohammed
    Hultman, C. Scott
    Caffrey, Julie A.
    BURNS & TRAUMA, 2019, 7 (01)
  • [36] Concise whole blood transcriptional signatures for incipient tuberculosis: a systematic review and patient-level pooled meta-analysis
    Gupta, Rishi K.
    Turner, Carolin T.
    Venturini, Cristina
    Esmail, Hanif
    Rangaka, Molebogeng X.
    Copas, Andrew
    Lipman, Marc
    Abubakar, Ibrahim
    Noursadeghi, Mahdad
    LANCET RESPIRATORY MEDICINE, 2020, 8 (04): : 395 - 406
  • [37] Totally Endoscopic Coronary Artery Bypass Graft: Systematic Review and Meta-Analysis of Reconstructed Patient-Level Data
    Zoupas, Ioannis
    Manaki, Vasiliki
    Tasoudis, Panagiotis T.
    Karela, Nina-Rafailia
    Avgerinos, Dimitrios V.
    Mylonas, Konstantinos S.
    INNOVATIONS-TECHNOLOGY AND TECHNIQUES IN CARDIOTHORACIC AND VASCULAR SURGERY, 2024,
  • [38] Reproductive and fetal outcomes in women with epilepsy: a systematic review and meta-analysis
    Kuang, Huimin
    Li, Yixun
    Lu, Yuling
    Zhang, Lin
    Wei, Lei
    Wu, Yuan
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2024, 37 (01):
  • [39] Impact of epilepsy surgery on quality of life: Systematic review and meta-analysis
    Shakhatreh, Lubna
    Foster, Emma
    Siriratnam, Pakeeran
    Neal, Andrew
    Carney, Patrick W.
    Jackson, Graeme D.
    O'Brien, Terence J.
    Kwan, Patrick
    Chen, Zhibin
    Ademi, Zanfina
    EPILEPSIA, 2023, 64 (07) : 1709 - 1721
  • [40] Treatment Outcomes of Newly Diagnosed Epilepsy: A Systematic Review and Meta-analysis
    Mubeen Janmohamed
    Haris Hakeem
    Suyi Ooi
    Suhailah Hakami
    Lily Vu
    Piero Perucca
    Terence J. O’Brien
    Ana Antonic-Baker
    Zhibin Chen
    Patrick Kwan
    CNS Drugs, 2023, 37 : 13 - 30